Status:

UNKNOWN

Use of Mobile App to Enhance Geriatric Hip Fracture Rehabilitation

Lead Sponsor:

Hospital Authority, Hong Kong

Collaborating Sponsors:

The Hong Kong Polytechnic University

Conditions:

Hip Fractures

Rehabilitation

Eligibility:

All Genders

60-90 years

Phase:

NA

Brief Summary

The steady increase in the incidence of geriatric hip fracture places an increasing burden on health care service in Hong Kong. Post fracture limitations are prominent and restrain many of the elderly...

Eligibility Criteria

Inclusion

  • All participants who completed the inpatient Geriatric Hip Fracture Rehabilitation Program in the Department of Orthopedic Rehabilitation (DOR) of TPH will be recruited by convenience sampling before discharge. To be eligible for enrolment, participants should:
  • have a primary diagnosis of hip fracture,
  • be 60 to 90 years old,
  • be literate enough to read and understand simple questions in Chinese,
  • be discharged home and taken care by caregiver,
  • have at least level III measured by Modified Functional Ambulatory Category (MFAC) upon discharge,
  • have access to a smart phone or tablets (iOS or Android platform)
  • have signed the written informed consent.

Exclusion

  • Participants will be excluded from the study if they:
  • have a bilateral hip fracture or hip fracture is the result of a malignancy,
  • have significant cognitive deficits,
  • have significant cardiopulmonary contraindications or preexisting conditions that precluded participation in an exercise program,
  • have a terminal illness (survival expected to be \<1 year),
  • have severe visual deficits or legally blind,
  • have request that their participation be terminated. All eligible participants will be given a detailed explanation and ethics approval will be obtained from the Joint CUHK-NTEC CREC prior to commencing the study.

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2022

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT04053348

Start Date

October 1 2019

End Date

October 1 2022

Last Update

February 10 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tai Po Hospital

Hong Kong, Hong Kong